Moreover, Mdivi-1 targeted Drp1 and siRNA silencing of Drp1 effectively increased the mitochondrial membrane potential (MMP), the generation of ROS, and apoptosis in breast cancer cells (81). Here, DNM1L is linked to breast carcinoma.